The human skin functionality decreases with age, which leads to problems such as reduced subcutaneous fat, slow healing, raised sensitivity to ultraviolet (UV) radiation, and increased susceptibility to skin infections. Hence, the growing geriatric population results in the prevalence of skin diseases, such as intertrigo, as atrophy, pruritus, and candidiasis infection. All of these are being increasingly cured with pharmaceutical products, which is resulting in the growth of the dermatology drugs sector.
Further, the number of people aged 80 or above is expected to rise massively during the forecast period. The data for the geriatric population along with the rising prevalence of skin diseases in the elderly predicts a heavy need for dermatological products. Thus, the growing aging population and increasing prevalence of skin diseases are driving the dermatology drugs sector across the globe.